Normally, the immune system is able to clear tumour, or hold it in a state of ‘equilibrium’ through innate (natural killer and dendritic cells) and adaptive (CD4 and CD8 T cells) mechanisms, until mutating tumour cells acquire the ability to evade detection or elimination [37] and therefore progress to a clinically significant pathology [38]. The gene discussed is CD8A; the disease is neoplasm.